Stephanie Wolff
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The use of cladribine tablets in patients with MS beyond the age of 50: experiences from a large tertiary German centre.
Journal: Neurological research and practice
Published: April 01, 2026
Neuropsychological symptoms and subclinical disease activity in multiple sclerosis patients receiving high-efficacy therapy.
Journal: Multiple sclerosis and related disorders
Published: December 18, 2025
Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 04, 2025
Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysis.
Journal: Therapeutic advances in neurological disorders
Published: October 02, 2025
Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 30, 2025
Association of body mass index and clinical response in patients receiving ofatumumab for treatment of multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: December 16, 2024
Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab.
Journal: Annals of neurology
Published: April 08, 2024
Rapid healing of a patient with dramatic subacute combined degeneration of spinal cord: a case report.
Journal: BMC research notes
Published: August 16, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026